A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
Recruiting now · Phase 2
Conditions studied: Acute Pancreatitis
In brief
The goal of this clinical trial is to test the safety and effectiveness of a single dose of RABI-767 given by endoscopic ultrasound (EUS) guided peripancreatic injection in participants with predicted severe acute pancreatitis. The main question the study aims to answer is: • Is a single-dose of RABI-767 given by EUS-guided peripancreatic injection safe in patients with predicted severe acute pancreatitis. The study also aims to answer: • Is a single-dose of RABI-767 given by EUS-guided peripancreatic injection effective in treating patients with predicted severe acute pancreatitis. Study participants will be randomly assigned (like the flip of a coin) to receive a single dose of RABI-767 plus supportive care or supportive care only. The study sponsor will compare safety and efficacy data collected from participants who receive RABI-767 to participants who receive supportive care only to test if RABI-767 is safe and effective.
Key facts
- Study ID
- NCT06080789
- Run by
- Panafina, Inc.
- People needed
- 36
- Starts
- 2024-06-28
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-08-05
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Govind Ballabh Pant Institute of Postgraduate Medical Education and Research — New Delhi, India (enrolling)
- Keck Hospital of USC and LA County Hospital — Los Angeles, California, United States (enrolling)
- University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States (enrolling)
- University of Florida Health — Gainesville, Florida, United States (enrolling)
- Orlando Health — Orlando, Florida, United States (enrolling)
- UI Health, University of Illinois Chicago Hospital Health Sciences System — Chicago, Illinois, United States (enrolling)
- University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States (enrolling)
- Johns Hopkins Hospital — Baltimore, Maryland, United States (enrolling)
- Henry Ford Hospital — Detroit, Michigan, United States (enrolling)
- Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire, United States (enrolling)
- NYU Langone Medical Center — New York, New York, United States (enrolling)
- Lisie Hospital — Kochi, Kerala, India (enrolling)
- Christian Medical College (CMC) Vellore, Ranipet Campus — Vellore, TamiNadu, India (enrolling)
- Postgraduate Institute of Medical Education and Research — Chandigarh, India (enrolling)
- All India Institute of Medical Sciences — Delhi, India (enrolling)
- Indiana University Health University Hospital — Indianapolis, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.